Embla Medical hf. (CPH:EMBLA)
28.10
0.00 (0.00%)
Nov 6, 2026, 3:53 PM CET
Embla Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Embla Medical stock has a consensus rating of "Buy" and an average price target of kr 31.90. The average 1-year stock price forecast is 13.52% higher than the current stock price, while the lowest is kr 28.50 (+1.42%) and the highest is kr 35.00 (+24.56%).
Price Target: kr 31.90 (+13.52%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Embla Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
1.01B
from 928.69M
Increased by 9.01%
Revenue Next Year
1.08B
from 1.01B
Increased by 6.92%
EPS This Year
0.23
from 0.19
Increased by 24.28%
EPS Next Year
0.26
from 0.23
Increased by 12.72%
EPS and Forward PE are based on non-GAAP adjusted numbers.